Table 5.
Univariate | Multivariate | |||||||
---|---|---|---|---|---|---|---|---|
HR | CIlow | CIupp | p‐Value | HR | CIlow | CIupp | p‐Value | |
CD56 (high vs. low) | 0.29 | 0.15 | 0.55 | 0.0001* | 0.27 | 0.12 | 0.60 | 0.001* |
Tumor site | ||||||||
Oropharynx vs. oral cavity | 0.86 | 0.35 | 2.07 | 0.732 | ||||
Hypopharynx vs. oral cavity | 0.56 | 0.15 | 2.05 | 0.381 | ||||
pT stage (3–4 vs. 1–2) | 2.33 | 1.12 | 4.79 | 0.022* | ||||
Resection margin (ECE) | 2.28 | 0.92 | 5.65 | 0.075 | ||||
HPV16 DNA (pos vs. neg) | 0.29 | 0.07 | 1.10 | 0.070 | ||||
p16 (pos vs. neg) | 0.60 | 0.20 | 1.85 | 0.377 | ||||
p53 (pos vs. neg) | 1.06 | 0.46 | 2.48 | 0.885 |
Abbreviations: HR, hazard ratio; CIlow/upp, lower and upper 95% confidence interval.
Bold values marked with * present p‐values <0.05 and are considered as statistically significant.